Kinetic behavior most consistent with the presence of two independent, but simultaneously acting, regulatory effector sites for prostaglandins has been presented for adenylate cyclase (EC 4.6.1.1) of rabbit intestinal epithelial cells. One site regulates activation of the catalytic site, while the other site regulates inhibition. A synthetic prostaglandin analogue, 7-oxa-13-prostynoic acid, is recognized at both sites in a concentration-dependent manner. At concentrations of 7-oxa-13-prostynoic acid less than 45 Ag/ml, activation is seen, while at higher concentrations, inhibition is seen. Different naturally occurring prostaglandins appear to be site-specific. Prostaglandin El gives only activation of the cyclase, while prostaglandin Al gives only inhibition of the activated cyclase. When saturating concentrations of prostaglandin E, are used to activate adenylate cyclase, no further activation by 7-oxa-13-prostynoic acid can be elicited, indicating that both molecules activate at the same site. The similarity of inhibition constants for both 7-oxa-13-prostynoic acid and prostaglandin A, suggests that the mode of binding is the same for both compounds and that they probably inhibit by acting at the same site. The inhibition by 7-oxa-13-prostynoic acid and by prostaglandin Al overrides enzyme activation produced by either Escherichia coli enterotoxin, prostaglandin El, or sodium fluoride, suggesting that in intestinal adenylate cyclase this site is the primary regulatory site (i.e., primary allosteric effector site) for enzyme activity. These data suggest that sites exist on adenylate cyclase which would allow prostaglandins to serve as the intracellular messengers by which the cell controls its adenylate-cyclase-mediated response to extracellular stimulation, as with hormones.
The dvsfunction caused bv the action of Vibrio cholerae (1) and Escherichia coli enterotoxins (2) can be characterized as the "first molecular infectious disease process." Both toxins activate adenylate cvclase (EC 4.6.1.1) in intestinal el)ithelial cells, turning on a cAMIP-mediated fluid transport system to a pathological degree (3, 4) . Prostaglandins have been suggested as having a possible, but uncertain role in this process (5) . The current study was designed to elucidate the nature of the interactions of p)rostag-landills with the E. coli and cholera enterotoxin-sensitive adenviate cvelase in intestinal elithelial cells.
It has been known for some time that l)rostaglandins interact with adenN-late cvclase in cells. Both inhibition (6) and more commuonly, activation of adenvlate cyclase has been seen as a consequence of this interaction. Prostaglandins have been suggested as feedback inhibitors of adenvlate cyclase (7) , and obligate intermediates (8, 9) between hormone reception and resulting stimulation of adenylate cyclase. The manner in which prostaglandins affect adenylate cyclase is not currently known. Evidence presented in this paper indicates there are specific p)rostaglandin sites on adenylate cyclase. Others have suggested that prostaglandins incorporate as structural elements into membrane adjacent to adenylate cyclase, deforming it and thus causing changes in activity (10) . Whatever the mode of interaction, it appears quite possible that prostaglandins may be the messengers modulating the behavior of activated intestinal adenylate cyclase. For this reason, we have examined the effects of prostaglandins and the lprostaglandin analogue, 7-oxa-13-prostynoic acid (PA) (11) , on the adenylate cyclase activity of intestinal el)ithelial cells. Kinetic study was Tao and Lilpmann (12) . Incubation mixtures were as described previously (4) mechanism is the appearance of a plateau or saturation stage in kinetic studies (14) . At high concentrations of effector relative to that of enzyme, the observed velocity of the reaction becomes independent of the effector concentration. It is evident from Fig. 1 that enterotoxin, PGE,, and fluoride ion stimulate adenylate cyclase in a saturating fashion. In each case, the form of the kinetics is simple hyperbolic, and not sigmoidal, indicating that there is no concentration-dependent interaction of activation sites [as is seen in the allosteric behavior of hemoglobin binding of 02 (15) Under these conditions, the Lineweaver-Burk forms are not affected by the enzyme-substrate interactions, but rather only by interactions between the activator and the enzyme. The generalization that only effector-enzyme, and not substrate-enzyme interactions are seen under our experimental conditions, applies to all of the following results and analysis.
The prostaglandin analogue, 7-oxa-13-prostynoic acid (PA) has previously been shown by Fried and cyclase by PA at concentrations below 45 ug/ml. Experimental data for the effect of PA on the fluoride, enterotoxin, and PGE,-stimulated enzyme are shown in Fig. 2 . As seen in this figure, except for the enzyme activated with saturating concentrations of PGEI, the resulting profile for the effects of PA on the activated intestinal adenylate cyclase was bellshaped.
In classical enzyme theory, a bell shape is interpreted as representing interaction of the same effector molecule with two independent sites, each of which has the opposite effect on activity. Since overall activity can only be seen when both sites are in their active form, a bell-shaped composite response will be seen upon varying effector concentration. Fig. 3 gives a schematic illustration of this variation. Mathematical treatments which justify this concept have been worked out by Dixon (17) and Alberty and Massey (18) for the case in which the effector molecule is a hydrogen ion (i.e., pH-rate behavior). However, the mathematics of the treatment are valid when used for variation of the rate with log concentration of any effector molecule (19) . The mathematical expression representing a bell-shaped variation of a rate constant is (18) kobs kiim k~~[ Xim [1] [ Fig. 4) Burton (20) . The The original mathematical formulation for the bell shape indicated the activity was a function of two independent sites with opposing effects. Since PA appears not to perturb the substrate, the two sites must be functionally both on adenylate cyclase. Two possible modes of PA action may be considered: either (1) PA acts initially to facilitate the reaction, and at a subsequent step acts to block the reaction (such as at k2 or k3 in the reaction scheme previously shown); or (2) the PA molecule is ambiguous and provides different kinds of information to two different sites on the enzyme. If the latter case is true, then it should be possible to resolve the two sites. Such a view implies finding a natural prostaglandin which only activates the enzyme; and a different natural prostaglandin which only inhibits the enzyme. It has been possible to find natural prostaglandins which resolve the two sites whose behavior is indicated schematically in Fig. 3 . A model for the activation site is present in the behavior of PGEI. Data for activation by PGE, have been shown previously in Fig. 1 Fig. 5 . LThe log-log form of plotting the inhibition curve allows estimation of the equilibrium constant for the PGA,-adenylate cyclase interaction as the value at the intersection of the two linear portions (18) .] A summary of the activation (K,,,t) and inhibition (Ki) constants for the effects of prostaglandins on intestinal adenylate cyclase is as follows: (1) (8) and thyrotropin (9) has been considered to indicate the probable requirement for prostaglandin biosynthesis in the activation of adenylate cyclase by these hormones. Three of the results presented above argue against such a conclusion based on the use of PA.
(1) We Instead, it appears that PA is a molecule that is recognized directly by adenylate cyclase. It produces effects unique to its molecular structure in its interaction with receptors regulating adenylate cyclase. The results presented above indicate that there is a concentration-dependent interaction between the prostaglandin-like molecule, PA, and intestinal adenylate cyclase. The observed pattern of stimulation at low concentrations and inhibition at high concentrations is best explained by postulation of two antagonistic sites of action for the molecule, much like the situation represented in pH-rate profiles of enzyme activity. A bell-shape occurs when two groups (e.g., a carboxyl and an amine) which ionize in opposite directions, must simultaneously be in ionized form for activity to occur (18) . The agreement between the experimental data for PA action and the appropriate mathematical expression shown in Fig. 4 is fairly conclusive evidence that true antagonistic sites of action for PA exist. That these sites are both functionally on the enzyme is highly likely from the fact that PA experimentally showed no interference with the concentration of the substrate Mg++-ATP, at concentrations of PA within the experimental range. The most reasonable interpretation of our data is that intestinal adenylate cyclase has two antagonistic prostaglandin allosteric sites which recognize PA, as shown schematically in Fig. 3 .
It is apparent from the behavior summarized above that PA must be an "ambiguous" molecule. It must look like two different naturally occurring messengers, one of which causes activation and one of which causes inhibition. A pattern for the activation site is present in the behavior of PGE1. Saturation profiles, with concomitant Lineweaver-Burk behavior as seen from Fig. 1 be drawn between the activating properties of PGEL and PA, the constants for activation are different. In order to establish that the two molecules act at the same site, competition between them for this site must be demonstrated. Competition for the activation site is evident from the behavior seen in Fig. 2 . When intestinal adenylate cyclase is activated with saturating amounts of PGE1, no further activation can be elicited by PA. This clearly demonstrates that PGEI and PA function at the same site to produce activation. A summary of the behavior of PGE1, PGA1, and PA is shown schematically in Fig. 3 .
The foregoing discussion has treated the interaction of different prostaglandin molecules as allosteric effectors acting on adenylate cyclase. Such treatment implies that the effector is binding directly on the enzyme molecule itself. This is somewhat in disagreement with recent proposals by Shaw, Jessup and Ramwell (10) is conventionally interpreted as representing total inhibition of a single site by a single PGA1 molecule (18) . The fact that one PGA, molecule inhibits one active site argues against the possibility that a simple large-scale incorporation of PGAI in a membrane component near the adenylate cyclase deforms the enzyme molecule and results in lessened activity.
The values for the PGA, inhibition constants (Kis) are quite similar. Irrespective of the nature of the prior activation, occupation of the inhibitory site by PGA, is sufficient to shut down all adenylate cyclase activity. This suggests that PGA1 or a similar molecule could be used to reduce the intracellular adenylate cyclase response to an extracellular messenger.
